Literature DB >> 21739221

Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.

Zhong-Xian Yang1, Shan-Shan Huo, Xiao-Fang Cheng, Zhi-Feng Xu, Zhen Cao, Jie-Xia Zeng, Ye-Yu Xiao, Ke-Zeng You, Wei Chen, Yan-Yan Liu, Ren-Hua Wu.   

Abstract

INTRODUCTION: The purpose of this study is to investigate brain metabolic changes in patients with amnestic mild cognitive impairment (aMCI) using multivoxel proton MR spectroscopy ((1)H-MVS).
METHODS: Fourteen aMCI patients and fifteen healthy control subjects participated in this experiment. All MR measurements were acquired using a 1.5-T GE scanner. (1)H-MVS point resolved spectroscopy (2D PROBE-CSI PRESS) pulse sequence (TE = 35 ms; TR = 1,500 ms; phase × frequency, 18 × 18) was used for acquiring MRS data. All data were post-processed using Spectroscopy Analysis by General Electric software and linear combination of model (LCModel). The absolute concentrations of N-acetylaspartate (NAA), choline (Cho), myoinositol (MI), creatine (Cr), and the metabolite ratios of NAA/Cr, Cho/Cr, MI/Cr, and NAA/MI were measured bilaterally in the posterior cingulate gyrus (PCG), inferior precuneus (Pr), paratrigonal white matter (PWM), dorsal thalamus (DT), and lentiform nucleus (LN).
RESULTS: Patients with aMCI displayed significantly lower NAA levels in the bilateral PCG (p < 0.01), PWM (p < 0.05), and left inferior Pr (p < 0.05). The metabolite ratio of NAA/MI was decreased in the bilateral PCG (p < 0.01) and PWM (p < 0.05) and in the left DT (p < 0.01). NAA/Cr was decreased in the left PCG (p < 0.01), DT (p < 0.05), right PWM (p < 0.05), and LN (p < 0.05). However, MI/Cr was elevated in the right PCG (p < 0.01) and left PWM (p < 0.05). Significantly increased Cho level was also evident in the left PWM (p < 0.05).
CONCLUSIONS: Our observations of decreased NAA, NAA/Cr, and NAA/MI, in parallel with increased Cho and MI/Cr might be characteristic of aMCI patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739221     DOI: 10.1007/s00234-011-0900-0

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  52 in total

1.  Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Authors:  G Chételat; B Desgranges; V de la Sayette; F Viader; F Eustache; J-C Baron
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

Review 2.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

3.  Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.

Authors:  Antonio Metastasio; Patrizia Rinaldi; Roberto Tarducci; Elena Mariani; Filippo T Feliziani; Antonio Cherubini; Gian Piero Pelliccioli; Gianni Gobbi; Umberto Senin; Patrizia Mecocci
Journal:  Neurobiol Aging       Date:  2005-06-04       Impact factor: 4.673

Review 4.  N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

Authors:  Norbert Schuff; Dieter J Meyerhoff; Susanne Mueller; Linda Chao; Diana Truran Sacrey; Kenneth Laxer; Michael W Weiner
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Validating the Chinese version of the Verbal Learning Test for screening Alzheimer's disease.

Authors:  Chiung Chih Chang; Joel H Kramer; Ker Neng Lin; Wen Neng Chang; Ya-Ling Wang; Chi-Wei Huang; Yu Ting Lin; Ching Chen; Pei Ning Wang
Journal:  J Int Neuropsychol Soc       Date:  2009-12-11       Impact factor: 2.892

6.  Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.

Authors:  Toshiyuki Watanabe; Akihiko Shiino; Ichiro Akiguchi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-05       Impact factor: 2.959

7.  Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease.

Authors:  Ruth M Dixon; Kevin M Bradley; Marc M Budge; Peter Styles; A David Smith
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

8.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease.

Authors:  Sophie Chantal; Claude M J Braun; Rémi W Bouchard; Martin Labelle; Yvan Boulanger
Journal:  Brain Res       Date:  2004-04-02       Impact factor: 3.252

10.  Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

Authors:  Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

View more
  10 in total

1.  Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Authors:  Burcu Zeydan; Dinesh K Deelchand; Nirubol Tosakulwong; Timothy G Lesnick; Orhun H Kantarci; Mary M Machulda; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2017-06-29       Impact factor: 2.486

Review 2.  Metabolic Imaging in Humans.

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Top Magn Reson Imaging       Date:  2016-10

3.  Quantification of choline concentration following liver cell apoptosis using 1H magnetic resonance spectroscopy.

Authors:  Zhi-Wei Shen; Zhen Cao; Ke-Zeng You; Zhong-Xian Yang; Ye-Yu Xiao; Xiao-Fang Cheng; Yao-Wen Chen; Ren-Hua Wu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

Review 4.  Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.

Authors:  Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du
Journal:  Ageing Res Rev       Date:  2021-10-29       Impact factor: 10.895

5.  Brain neurometabolites differences in individuals with subjective cognitive decline plus: a quantitative single- and multi-voxel proton magnetic resonance spectroscopy study.

Authors:  Zhongxian Yang; Xing Wan; Xinzhu Zhao; Yu Rong; Yi Wu; Zhen Cao; Qiuxia Xie; Min Luo; Yubao Liu
Journal:  Quant Imaging Med Surg       Date:  2021-09

6.  Imaging of glutamate in acute traumatic brain injury using chemical exchange saturation transfer.

Authors:  Yifei Mao; Zerui Zhuang; Yanzi Chen; Xiaolei Zhang; Yuanyu Shen; Guisen Lin; Renhua Wu
Journal:  Quant Imaging Med Surg       Date:  2019-10

7.  The Neurochemical and Microstructural Changes in the Brain of Systemic Lupus Erythematosus Patients: A Multimodal MRI Study.

Authors:  Zhiyan Zhang; Yukai Wang; Zhiwei Shen; Zhongxian Yang; Li Li; Dongxiao Chen; Gen Yan; Xiaofang Cheng; Yuanyu Shen; Xiangyong Tang; Wei Hu; Renhua Wu
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

8.  Nuclear magnetic resonance spectroscopy is highly sensitive for lipid-soluble metabolites.

Authors:  Haiyang Dai; Bikai Hong; Zhifeng Xu; Lian Ma; Yaowen Chen; Yeyu Xiao; Renhua Wu
Journal:  Neural Regen Res       Date:  2013-08-05       Impact factor: 5.135

9.  Alterations in brain metabolism and function following administration of low-dose codeine phosphate: 1H-magnetic resonance spectroscopy and resting-state functional magnetic resonance imaging studies.

Authors:  Zhen Cao; Pei-Yin Lin; Zhi-Wei Shen; Ren-Hua Wu; Ye-Yu Xiao
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

10.  In vivo proton magnetic resonance spectroscopy (1H-MRS) evaluation of the metabolite concentration of optic radiation in primary open angle glaucoma.

Authors:  Sabrilhakim Sidek; Norlisah Ramli; Kartini Rahmat; Norlina Mohd Ramli; Fadzlina Abdulrahman; Tan Li Kuo
Journal:  Eur Radiol       Date:  2016-03-04       Impact factor: 5.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.